drugset / Trial / NCT05728424

One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIAL

NCT05728424

RandomizedParallel-groupQuadruple-blindTreatment

Summary

1. To assess the efficacy of the duration of Vonoprazan based triple regimen (one versus two weeks), in the eradication of H-pylori among patients attending gastroenterology clinics of Karachi, Pakistan. 2. To assess the improvement in the quality of life of patients receiving Vonoprazan as part of the triple regimen.

Timeline

Start
2022-09-20
Primary completion
2023-04-01
Completion
2023-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 1 g
Comparator Levofloxacin Small molecule 500 mg
Comparator Vonoprazan Other / unclassified 20 mg